Chitosan-based Nanoparticles in Mucosal Vaccine Delivery

AUTHORS

M. Mehrabi 1 , H. Montazeri 2 , N. Mohamadpour Dounighi 3 , * , A. Rashti 1 , R. Vakili-Ghartavol 1

1 Department of Medical Nanotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

2 Department of Medical Nanotechnology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Human Vaccine and Serum, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj Iran

How to Cite: Mehrabi M, Montazeri H, Mohamadpour Dounighi N, Rashti A, Vakili-Ghartavol R. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery, Arch Razi Inst. 2018 ; 73(3):e84822. doi: 10.22092/ari.2017.109235.1101.

ARTICLE INFORMATION

Archives of Razi Institute: 73 (3); 165-176
Published Online: September 01, 2018
Article Type: Review
Received: January 18, 2017
Accepted: June 18, 2018
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Most infectious diseases are caused by pathogenic infiltrations from the mucosal tract. Nowadays, the use of vaccines has been widely investigated for the prevention of different infectious diseases, infertility, immune disorders, malignancies, and allergies. Broad-spectrum adjuvant substances have been studied for immune system stimulation with a greater efficiency against specific antigens. Various adjuvants have been developed such as inorganic, oil-based, and emulsion adjuvants, bacterial products and their derivatives, cytokines, cytosine-guanine dinucleotide (CpG) motifs, and particulate systems. Mucosal vaccine delivery is an alternative route to induce both humoral and cellular immune responses. Applying nanoparticles in vaccine formulations allows not only improved antigen stability and immunogenicity, but also targeted delivery, and consequently, more specific release of the agent of interest. Chitosan nanoparticles have immunological activity and mucoadhesive properties. They have been used as a mucosal vaccine delivery system for many antigens. This review provides an overview of the recent advances in chitosan nanoparticles as a novel mucosal vaccine delivery system.

© 2018, Archives of Razi Institute. Razi Vaccine and Serum Research Institute.

Fulltext

COMMENTS

LEAVE A COMMENT HERE: